Author Archives: Lu Rahman

#Covid-19 #Immunology / Virology & Vaccines

Swiss government authorises Moderna vaccine and secures 7.5 million doses

Swissmedic, the Swiss Agency for Therapeutic Products, has authorised the COVID-19 Moderna Vaccine in Switzerland. The authorisation is given according to the ordinary approvals procedure and is based on a rolling submission of data and the totality of scientific evidence shared by the company, including a data analysis from the… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Biotechnology #Pharmaceuticals

Reach Separations pushes expansion plans and alliance with NovAliX 

Purification specialists Reach Separations and French drug discovery CRO, NovAliX, have entered into an alliance to develop supercritical fluid chromatography (SFC) capabilities at the NovAliX facility near Strasbourg. Formed in support of Reach Separations’ strategy to grow its European presence, and in response to a sustained rise in demand for… Read More

#News

#AI / data analytics / healthtech / informatics #Drug development #Drug discovery #Therapeutics

Boehringer Ingelheim and Google in R&D partnership

Boehringer Ingelheim has entered a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations. The new partnership combines Boehringer Ingelheim’s leading expertise in the field of computer-aided drug design and… Read More

#Editor's Choice #News

#Cellular & Molecular biology

Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology

Mogrify and the MRC Laboratory of Molecular Biology (LMB), a research laboratory dedicated to understanding important biological processes at the molecular level, have announced an exploratory research collaboration. The project aims to develop novel protein expression systems by leveraging recent advances in direct cell reprogramming to help improve the production… Read More

#News

#Biologics #Biotechnology #Vaccines

German biotech Leukocare opens in the US

Leukocare, a German biotechnology company specialising in formulation development for biologics, viral vectors and vaccines, has opened development labs in Milford, USA. Its headquarters will remain in Martinsried/Munich, Germany. Being present in the US market offers the opportunity to collaborate closely with customers and partners on tailor-made solutions in the… Read More

#News

#Report

New inquiry examines equity in the STEM workforce

The All-Party Parliamentary Group (APPG) on Diversity and Inclusion in Science, Technology, Engineering and Maths (STEM) has launched its inquiry into Equity in the UK STEM workforce. Following on from the APPG on Diversity and Inclusion in STEM’s inquiry into Equity in STEM Education that focussed on the education pipeline,… Read More

#Editor's Choice #News

#Covid-19 #Immunology / Virology & Vaccines

Moderna vaccine becomes third COVID-19 to be approved by UK regulator

The COVID-19 vaccine developed by Moderna has been given regulatory approval for supply by the Medicines and Healthcare products Regulatory Agency (MHRA). This follows a thorough and rigorous assessment by the MHRA’s teams of scientists, including advice from the independent Commission on Human Medicines, which reviewed in depth all the… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Covid-19 #Immunology / Virology & Vaccines

Novavax seals agreement with Australia for 51 million doses of COVID-19 Vaccine

Novavax has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate. This follows an agreement in principle that was announced in November 2020. NVX-CoV2373 is a recombinant protein vaccine adjuvanted with Novavax’ proprietary Matrix-M to enhance the immune response. Read More

#Covid-19 #Editor's Choice #News #Trending News

#Stem cells

REPROCELL launches personalised iPSC production service

REPROCELL’s new service – Personal iPS – will generate individual specific induced pluripotent stem cells (iPSC). The company will start taking orders from this month (January 2021) in Japan and has also launched a new B2C website to promote this service, which is currently only available in Japan. Personal iPS… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines

European Commission authorises Moderna COVID-19 vaccine in Europe

The European Commission has granted a conditional marketing authorisation (CMA) for Moderna’s COVID-19 vaccine Moderna, allowing vaccination programs using the Moderna vaccine to be rolled out across the European Union. The authorisation is based upon the recommendation of the European Medicines Agency (EMA) for use of the COVID-19 Vaccine Moderna… Read More

#Covid-19 #Editor's Choice #News #Trending News

#AI / data analytics / healthtech / informatics #Genes

Researchers use deep learning to identify gene regulation at single-cell level

Scientists at the University of California, Irvine have developed a new deep-learning framework that predicts gene regulation at the single-cell level. Deep learning, a family of machine-learning methods based on artificial neural networks, has revolutionized applications such as image interpretation, natural language processing and autonomous driving. In a study published… Read More

#Editor's Choice #News

#Covid-19 #Immunology / Virology & Vaccines #Life sciences #Oncology #Therapies

The life sciences industry has learned a lot from COVID-19, but there’s more to be done

By Dr Steve Arlington, President, The Pistoia Alliance COVID-19 has dealt the life sciences a host of challenges, but it’s also been the catalyst for positive change. As the industry has turned its resources towards developing critical vaccines and therapies, organisations, governments, regulators, researchers and academia have come together in… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Cell and Gene Therapy Catapult #Cell therapy #Gene therapy

Funding to UK cell and gene therapy training centre to strengthen skills pipeline

The Cell and Gene Therapy Catapult (CGT Catapult) and Hertfordshire Local Enterprise Partnership (LEP) in the UK have announced that a new cell and gene therapy integration laboratory at the CGT Catapult facility in Stevenage will be part-funded by the government’s Getting Building Fund. The new laboratory will be exclusively… Read More

#Editor's Choice #News